These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 8307014)
1. Mechanisms involved in serum-dependent inactivation of the immunotoxin enhancers monensin and carrier-protein-monensin. Franceschi A; Dosio F; Anselmi C; Chignola R; Candiani C; Pasti M; Tridente G; Colombatti M Eur J Biochem; 1994 Jan; 219(1-2):469-79. PubMed ID: 8307014 [TBL] [Abstract][Full Text] [Related]
2. Blocking effect of human serum but not of cerebrospinal fluid on ricin A chain immunotoxin potentiation by monensin or carrier protein-monensin conjugates. Candiani C; Franceschi A; Chignola R; Pasti M; Anselmi C; Benoni G; Tridente G; Colombatti M Cancer Res; 1992 Feb; 52(3):623-30. PubMed ID: 1732050 [TBL] [Abstract][Full Text] [Related]
3. Carrier protein-monensin conjugates: enhancement of immunotoxin cytotoxicity and potential in tumor treatment. Colombatti M; Dell'Arciprete L; Chignola R; Tridente G Cancer Res; 1990 Mar; 50(5):1385-91. PubMed ID: 2302703 [TBL] [Abstract][Full Text] [Related]
5. Recombinant ricin A chain conjugated to monoclonal antibodies: improved tumor cell inhibition in the presence of lysosomotropic compounds. Ramakrishnan S; Bjorn MJ; Houston LL Cancer Res; 1989 Feb; 49(3):613-7. PubMed ID: 2783383 [TBL] [Abstract][Full Text] [Related]
6. Monensin in lipid emulsion for the potentiation of ricin A chain immunotoxins. Griffin T; Raso V Cancer Res; 1991 Aug; 51(16):4316-22. PubMed ID: 1868454 [TBL] [Abstract][Full Text] [Related]
7. Potentiation of antitumor immunotoxins by liposomal monensin. Griffin T; Rybak ME; Recht L; Singh M; Salimi A; Raso V J Natl Cancer Inst; 1993 Feb; 85(4):292-8. PubMed ID: 8426373 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of the specific cytotoxicity of a breast cancer-associated antigen immunotoxin by the carboxylic ionophore monensin. Griffin TW; Pagnini PG; Houston LL J Biol Response Mod; 1987 Oct; 6(5):537-45. PubMed ID: 3500277 [TBL] [Abstract][Full Text] [Related]
9. Cationomycin and monensin partition between serum proteins and erythrocyte membrane: consequences for Na+ and K+ transport and antimalarial activities. Gibot S; Jeminet G; Juillard J; Gumila C; Ancelin ML; Vial H; Delort AM Arch Biochem Biophys; 1999 Mar; 363(2):361-72. PubMed ID: 10068460 [TBL] [Abstract][Full Text] [Related]
10. Trichokirin, a ribosome-inactivating protein from the seeds of Trichosanthes kirilowii Maximowicz. Purification, partial characterization and use for preparation of immunotoxins. Casellas P; Dussossoy D; Falasca AI; Barbieri L; Guillemot JC; Ferrara P; Bolognesi A; Cenini P; Stirpe F Eur J Biochem; 1988 Oct; 176(3):581-8. PubMed ID: 3262509 [TBL] [Abstract][Full Text] [Related]
11. The effect of monensin and chloroquine on the endocytosis and toxicity of chimeric toxins. Ippoliti R; Ginobbi P; Lendaro E; D'Agostino I; Ombres D; Benedetti PA; Brunori M; Citro G Cell Mol Life Sci; 1998 Aug; 54(8):866-75. PubMed ID: 9760993 [TBL] [Abstract][Full Text] [Related]
12. In vitro cytotoxicity of recombinant ricin A chain-antitransferrin receptor immunotoxin against human adenocarcinomas of the colon and pancreas. Griffin TW; Pagnini PG; McGrath JJ; McCann JC; Houston LL J Biol Response Mod; 1988 Dec; 7(6):559-67. PubMed ID: 3265147 [TBL] [Abstract][Full Text] [Related]
13. Identification of human plasma proteins as major clients for the extracellular chaperone clusterin. Wyatt AR; Wilson MR J Biol Chem; 2010 Feb; 285(6):3532-3539. PubMed ID: 19996109 [TBL] [Abstract][Full Text] [Related]
14. Binding of aluminum to human serum transferrin, human serum albumin and rat serum proteins. el-Sebae AK; Abou Zeid MM; Abdel-Rahman FH; Saleh MA J Environ Sci Health B; 1994 Mar; 29(2):303-21. PubMed ID: 8169318 [TBL] [Abstract][Full Text] [Related]
15. [High molecular-weight polymers in human albumin solutions. Quantitative determination by polyacrylamide gradient electrophoresis]. Lambin P; Rochu D; Herance N; Fine JM Rev Fr Transfus Immunohematol; 1982 Oct; 25(5):487-98. PubMed ID: 7163729 [TBL] [Abstract][Full Text] [Related]
16. Endocytosis of immunotoxin-791T/36-RTA by tumor cells in relation to its cytotoxic action. Byers VS; Pawluczyk IZ; Hooi DS; Price MR; Carroll S; Embleton MJ; Garnett MC; Berry N; Robins RA; Baldwin RW Cancer Res; 1991 Apr; 51(8):1990-5. PubMed ID: 2009518 [TBL] [Abstract][Full Text] [Related]
17. Binding of macrophage colony-stimulating factor to serum proteins. Ohtsuki T; Hatake K; Ikeda M; Yamada M; Motoyoshi K; Miura Y Exp Hematol; 1996 Feb; 24(2):101-7. PubMed ID: 8641330 [TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of intraperitoneal immunotoxins in a nude mouse model of human malignant mesothelioma. Griffin TW; Richardson C; Houston LL; LePage D; Bogden A; Raso V Cancer Res; 1987 Aug; 47(16):4266-70. PubMed ID: 3496960 [TBL] [Abstract][Full Text] [Related]
19. Purification and characterization of a cobalt-activated carboxypeptidase from the hyperthermophilic archaeon Pyrococcus furiosus. Cheng TC; Ramakrishnan V; Chan SI Protein Sci; 1999 Nov; 8(11):2474-86. PubMed ID: 10595552 [TBL] [Abstract][Full Text] [Related]
20. Enhancement by a serum factor of the immunoaccessibility of an enterobacterial porin protein domain. Henriksen AZ; Maeland JA APMIS; 1991 Aug; 99(8):703-10. PubMed ID: 1650236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]